Editor’s note: Broadcast-quality video and audio can be found here. This video content is cleared for use by media outlets on all digital and broadcast platforms, with credit to Dartmouth Health. Transcripts are at the bottom of this release.
The Pan American Health Organization (PAHO) announced on Tuesday that measles is no longer eliminated in the United States—a disappointing but unsurprising development given recent outbreaks, said Christopher A. Ohl, MD, infectious disease physician at Dartmouth Health’s Dartmouth Hitchcock Medical Center, during Dartmouth Health’s PressRx virtual media availability on Tuesday.
The U.S. earned elimination status in 2000 following a long vaccination campaign that began in the 1960s. However, elimination status does not mean measles was fully eradicated, Ohl said. Elimination status is granted after 12 months without continuous domestic transmission of the same strain. Losing that status means that the U.S. has seen continuous transmission.
The announcement from PAHO reflects ongoing measles transmission in the U.S. and underscores the importance of addressing gaps in vaccination coverage, particularly in communities where rates fall well below the 95% threshold associated with herd immunity.
“This is a reminder to us that measles remains a very real public health threat when vaccination rates decline,” said Ohl.
While overall measles vaccination rates remain relatively high across New England, statewide averages can obscure significant differences between communities. Massachusetts has an estimated vaccination rate of 98%, while New Hampshire and Vermont sit near 93%. These figures, however, can mask localized pockets of lower coverage. In parts of New Hampshire and Vermont, rates are as low as 65%.
Several factors contribute to gaps in vaccination, including vaccine hesitancy, barriers to accessing healthcare, and disruptions to routine childhood immunizations during the COVID-19 pandemic. Some children who missed vaccinations during that period have not yet caught up, according to Ohl.
The most important step individuals and families can take is to ensure they are up to date on the measles, mumps, and rubella (MMR) vaccine, said Ohl. The standard childhood vaccine schedule includes two doses: the first at 12 to 15 months of age, and the second between ages four to six.
Adults who are unsure of their vaccination history should check their records if they have them or talk to their healthcare provider about whether a second dose is recommended. Some adults may have only received one dose, depending on when they were vaccinated. Two doses over a lifetime are considered sufficient for measles immunity.
Measles is among the most contagious infectious diseases, according to Ohl. People infected with the virus can spread it before developing the characteristic rash, making it possible to unknowingly expose others.
“Measles is not just a childhood rash or minor illness. Measles can be a very serious illness,” said Ohl. “I had measles when I was a very young child. I can tell you, it’s miserable. I can still remember it to this day.”
Symptoms typically develop about two weeks after exposure, although the incubation period can extend up to 21 days. Measles pneumonia occurs in about 1 in 20 people, and about 1 in 5,000 people die from the disease. Measles can also cause encephalitis, or inflammation of the brain, which may occur weeks or months after infection.
Because measles has been so uncommon in the U.S. for decades, many healthcare providers have never encountered a case firsthand, according to Ohl. Dartmouth Health is working to educate clinicians about recognizing measles symptoms, evaluating potentially exposed patients, and preventing further transmission. Dartmouth Health also works closely with state and local officials to coordinate a response if cases occur in the region.
“Health systems have an important role to play, not only in treating patients with measles, but helping our communities understand the importance of vaccination and connecting people with the resources to get vaccinated,” said Ohl.
Above all, Ohl said the best way for people to protect themselves against the disease is to ensure they are fully vaccinated.
Transcripts:
(0:15) “While this news is disappointing, and somewhat sad, actually, it’s not surprising given how many outbreaks we’ve seen over the past year. Those of us in public health and infectious diseases have been anticipating this for some time.”
(0:13) “It doesn’t mean now that we’ve lost elimination status that public health efforts stop. In fact, they’ll increase. Surveillance, case investigation, vaccination, and outbreak response will continue.”
(0:18) “Hopefully we can garner some more resources, both from government and private sources. Those resources then can be used to help shore up public health. We need to get out and have some outreach into these areas where we have pockets of people who are unvaccinated.”
(0:15) “So health systems have an important role to play, not only in treating people with measles, but helping our communities understand the importance of vaccination and connecting people with the resources to get vaccinated.”
About Dartmouth Health
Dartmouth Health, New Hampshire’s only academic health system and largest private employer, serves patients across New England. Dartmouth Health provides access to more than 2,300 providers in nearly every area of medicine, delivering care at its flagship hospital, Dartmouth Hitchcock Medical Center (DHMC) in Lebanon, NH. Its network of hospitals, outpatient centers, clinics and home care facilities, spans a broad geographical area. Year after year, DHMC is named the #1 hospital in New Hampshire by U.S. News & World Report, and is consistently recognized for high performance in numerous clinical specialties and procedures. Dartmouth Health includes Dartmouth Cancer Center, northern New England’s only National Cancer Institute-designated Comprehensive Cancer Centers and one of less than than 60 total nationally; Dartmouth Health Children’s, which includes the state’s only children’s hospital, the Golisano Children's Hospital at Dartmouth Health, and more than 20 locations around the region; eight member hospitals in Lebanon, Keene, Claremont, Hampstead, and New London, NH, and Windsor and Bennington, VT; Dartmouth Health Home Care; Dartmouth Health Connected Care Center for Telehealth, serving patients as far away as Texas; and more than 30 primary and multi-specialty clinics across New Hampshire and Vermont. Through its partnership with Dartmouth College, Dartmouth’s Geisel School of Medicine and the White River Junction VA Medical Center, Dartmouth Health trains nearly 400 medical residents and fellows annually and performs cutting-edge research and clinical trials with international impact. Dartmouth Health and its more than 16,000 employees are committed to serving the healthcare needs of everyone in the communities it serves and to providing every patient with exceptional, state-of-the-art, personalized care. Learn more at dartmouth-health.org.